Key information: • Cumulative sales amounted to €20.7bn for the 9m 17, an increase of 2% compared with 9m 16. On a lfl basis, sales were also 2% higher. • EBITDA up by 2% only due to the collapse in Asia’s EBITDA by 45% over the 9m period. • To date in 2017, the group has spent c.€1.34bn on 27 acquisition/investment transactions. • Management expects year-end net debt to be in line with last year’s (2016: €5.3bn).
22 Nov 2017
CRH uses a value-creating bazooka for acquisitions
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
CRH uses a value-creating bazooka for acquisitions
CRH public limited company (CRH:LON) | 6,247 -874.6 (-0.2%) | Mkt Cap: 43,165m
- Published:
22 Nov 2017 -
Author:
Felix Brunotte -
Pages:
4
Key information: • Cumulative sales amounted to €20.7bn for the 9m 17, an increase of 2% compared with 9m 16. On a lfl basis, sales were also 2% higher. • EBITDA up by 2% only due to the collapse in Asia’s EBITDA by 45% over the 9m period. • To date in 2017, the group has spent c.€1.34bn on 27 acquisition/investment transactions. • Management expects year-end net debt to be in line with last year’s (2016: €5.3bn).